Efficacy and safety of arbidol (umifenovir) in patients with COVID‐19: A systematic review and meta‐analysis
Abstract Objective To provide the latest evidence for the efficacy and safety of arbidol (umifenovir) in COVID‐19 treatment. Methods A literature systematic search was carried out in PubMed, Cochrane Library, Embase, and medRxiv up to May 2021. The Cochrane risk of bias tool and Newcastle–Ottawa sca...
Guardado en:
Autores principales: | Behnam Amani, Bahman Amani, Sara Zareei, Mahsa Zareei |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c8053bcce894c5ca01afc66ae041c69 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
por: Ruby A. Escobedo, et al.
Publicado: (2021) -
Desinfección de Alicates de Ortodoncia. Actualización de Recomendaciones en Contexto de COVID- 19. Revisión de la Literatura
por: Munizaga-Naveillan,María Soledad, et al.
Publicado: (2021) -
Recommendations for prevention and management of COVID-19 in peritoneal dialysis patients
por: Xue-Li Lai, et al.
Publicado: (2020) -
Detection of SARS-CoV-2 in Wastewater at Residential College, Maine, USA, August–November 2020
por: Yolanda M. Brooks, et al.
Publicado: (2021) -
Palestinian strategies, guidelines, and challenges in the treatment and management of coronavirus disease-2019 (COVID-19)
por: Hatem A Hejaz
Publicado: (2020)